CervoMed Inc. Amortization of Debt Discount (Premium)
CervoMed Inc. (CRVO) reported Amortization of Debt Discount (Premium) of $1.36 thousand for the 3-month period ending 2018-03-31, per its 10-Q filed 2019-05-09.
Discontinued › Cash Flow › Operating Activities
us-gaap:AmortizationOfDebtDiscountPremium · last filed 2019-05-09
- CervoMed Inc. amortization of debt discount (premium) for the quarter ending 2018-03-31 was $1.36K, a 97.63% decline year-over-year.
- CervoMed Inc. amortization of debt discount (premium) for the quarter ending 2017-12-31 was $21.55K, a 31.32% decline year-over-year.
- CervoMed Inc. amortization of debt discount (premium) for the quarter ending 2017-09-30 was -$73.34K, a 3270.86% decline year-over-year.
- CervoMed Inc. amortization of debt discount (premium) for the quarter ending 2017-06-30 was $28.12K, a 1951.35% increase year-over-year.
- CervoMed Inc. amortization of debt discount (premium) for fiscal 2017 was $33.52K, a 12.82% decline from fiscal 2016.
- CervoMed Inc. amortization of debt discount (premium) for fiscal 2016 was $38.45K, a 76.75% decline from fiscal 2015.
- CervoMed Inc. amortization of debt discount (premium) for fiscal 2015 was $165.33K.
| Period end | Amortization of Debt Discount (Premium) 3 month | Amortization of Debt Discount (Premium) 6 month | Amortization of Debt Discount (Premium) 9 month | Amortization of Debt Discount (Premium) 12 month |
|---|---|---|---|---|
| 2018-03-31 | $1.36K 10-Q · filed 2019-05-09 | $22.91K derived: sum of 2 quarters · filed 2019-05-09 | -$50.44K derived: sum of 3 quarters · filed 2019-05-09 | -$22.31K derived: sum of 4 quarters · filed 2019-05-09 |
| 2017-12-31 | $21.55K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-19 | -$51.79K derived: sum of 2 quarters · filed 2019-03-19 | -$23.67K derived: sum of 3 quarters · filed 2019-03-19 | $33.52K 10-K · filed 2019-03-19 |
| 2017-09-30 | -$73.34K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-13 | -$45.22K derived: sum of 2 quarters · filed 2018-11-13 | $11.97K 10-Q · filed 2018-11-13 | $43.35K derived: sum of 4 quarters · filed 2018-11-13 |
| 2017-06-30 | $28.12K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-10 | $85.31K 10-Q · filed 2018-08-10 | $116.69K derived: sum of 3 quarters · filed 2018-08-10 | $119.00K derived: sum of 4 quarters · filed 2018-08-10 |
| 2017-03-31 | $57.19K 10-Q · filed 2018-05-10 | $88.56K derived: sum of 2 quarters · filed 2018-05-10 | $90.88K derived: sum of 3 quarters · filed 2018-05-10 | $92.25K derived: sum of 4 quarters · filed 2018-05-10 |
| 2016-12-31 | $31.38K derived: 10-K 12 month − 10-Q 9 month · filed 2018-04-02 | $33.69K derived: sum of 2 quarters · filed 2018-04-02 | $35.06K derived: sum of 3 quarters · filed 2018-04-02 | $38.45K 10-K · filed 2018-04-02 |
| 2016-09-30 | $2.31K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-13 | $3.68K derived: sum of 2 quarters · filed 2017-11-13 | $7.07K 10-Q · filed 2017-11-13 | $12.08K derived: sum of 4 quarters · filed 2017-11-13 |
| 2016-06-30 | $1.37K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-14 | $4.75K 10-Q · filed 2017-08-14 | $9.77K derived: sum of 3 quarters · filed 2017-08-14 | $78.74K derived: sum of 4 quarters · filed 2017-08-14 |
| 2016-03-31 | $3.38K 10-Q · filed 2017-05-15 | $8.40K derived: sum of 2 quarters · filed 2017-05-15 | $77.37K derived: sum of 3 quarters · filed 2017-05-15 | $112.36K derived: sum of 4 quarters · filed 2017-05-15 |
| 2015-12-31 | $5.01K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-31 | $73.98K derived: sum of 2 quarters · filed 2017-03-31 | $108.98K derived: sum of 3 quarters · filed 2017-03-31 | $165.33K 10-K · filed 2017-03-31 |
| 2015-09-30 | $68.97K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-14 | $103.97K derived: sum of 2 quarters · filed 2016-11-14 | $160.31K 10-Q · filed 2016-11-14 | |
| 2015-06-30 | $34.99K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-15 | $91.34K 10-Q · filed 2016-08-15 | ||
| 2015-03-31 | $56.35K 10-Q · filed 2016-05-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 | |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |